{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:21:44Z","timestamp":1788873704118,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.mehy.2009.08.008","type":"journal-article","created":{"date-parts":[[2009,9,12]],"date-time":"2009-09-12T08:26:56Z","timestamp":1252744016000},"page":"67-70","source":"Crossref","is-referenced-by-count":10,"title":["The Double Strike Hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma"],"prefix":"10.1016","volume":"74","author":[{"given":"Dirk","family":"Michelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mehy.2009.08.008_bib1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/cncr.20296","article-title":"Therapy of meningeal melanocytomas","volume":"1000","author":"Rades","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2009.08.008_bib2","doi-asserted-by":"crossref","unstructured":"Ahmedin Jemal, Limin X. Clegg, Elizabeth Ward, Lynn AG Ries, Xiaocheng Wu, Patricia M. Jamison, et al. Annual Report to the Nation on the Status of Cancer, 1975\u20132001, with a special feature regarding survival. Cancer 2004;101(1):3\u201327.","DOI":"10.1002\/cncr.20288"},{"key":"10.1016\/j.mehy.2009.08.008_bib3","unstructured":"E. Helen Kemp, Elizabeth A. Waterman, Anthony P. Weetman. Immunological pathomechanisms in vitiligo. Expert reviews in molecular medicine (<www.expertreviews.org>), 23 July 2001, (01)00336-2h.htm Available from: <http:\/\/www-ermm.cbcu.cam.ac.uk\/01003362a.pdf>."},{"key":"10.1016\/j.mehy.2009.08.008_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.mehy.2009.08.008_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12476636","article-title":"Cytolytic antibodies to melanocytes in vitiligo","volume":"100","author":"Cui","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.mehy.2009.08.008_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1046\/j.1523-1747.2000.00130.x","article-title":"IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes","volume":"115","author":"Li","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.mehy.2009.08.008_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of the serum form patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib8","series-title":"Endocrine autoimmunity and associated conditions","first-page":"269","article-title":"Vitiligo","author":"Gawkrodger","year":"1998"},{"key":"10.1016\/j.mehy.2009.08.008_bib9","series-title":"Cutaneous medicine and surgery","first-page":"1210","article-title":"Vitiligo","author":"Boissy","year":"1995"},{"key":"10.1016\/j.mehy.2009.08.008_bib10","doi-asserted-by":"crossref","unstructured":"Kovacs SO Vitiligo. J Am Acad Dermatol 1998;38:647\u201366; quiz 667\u2013648, PubMed ID: 98252505. [cited in the Expert Reviews Article].","DOI":"10.1016\/S0190-9622(98)70194-X"},{"key":"10.1016\/j.mehy.2009.08.008_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"issue":"l.6","key":"10.1016\/j.mehy.2009.08.008_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.mehy.2009.08.008_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2009.08.008_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.mehy.2009.08.008_bib15","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1097-0142(19931015)72:8<2365::AID-CNCR2820720812>3.0.CO;2-G","article-title":"Vitiligo autoantibodies are effective against melanoma","volume":"72","author":"Fishman","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mehy.2009.08.008_bib16","first-page":"27","article-title":"Contact vitiligo: etiology and treatment","volume":"69","author":"Singh","year":"2003","journal-title":"Ind J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.mehy.2009.08.008_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","article-title":"A symbiotic concept of autoimmunity and tumor immunity: lessons from vitiligo","volume":"22","author":"Das","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.mehy.2009.08.008_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000247693","article-title":"Vitiligo and cutaneous melanoma","volume":"193","author":"Schallreuter","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.mehy.2009.08.008_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jso.2930130409","article-title":"Case report: malignant melanoma arising during drug therapy for vitiligo","volume":"13","author":"Forrest","year":"1980","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.mehy.2009.08.008_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247164","article-title":"Vitiligo and other diseases: coexistence or true association?","volume":"188","author":"Schallreuter","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.mehy.2009.08.008_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.1991.tb00383.x","article-title":"Prolonged survival in metastatic malignant melanoma associated with vitiligo","volume":"16","author":"Duhra","year":"1991","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.mehy.2009.08.008_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01517212","article-title":"Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism","volume":"38","author":"Ofer","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.mehy.2009.08.008_bib24","series-title":"The origin of species by means of natural selection","author":"Charles","year":"1859"},{"issue":"4","key":"10.1016\/j.mehy.2009.08.008_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/canjclin.46.4.225","article-title":"Vaccine therapy for malignant melanoma","volume":"46","author":"Morton","year":"1996","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.mehy.2009.08.008_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0749.1993.tb00584.x","article-title":"Vitiligo: where do we stand?","volume":"6","author":"Ortonne","year":"1993","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.mehy.2009.08.008_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0738-081X(97)00126-0","article-title":"Immune mechanisms in vitiligo","volume":"15","author":"Bystryn","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib29","first-page":"698","article-title":"Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment","volume":"3","author":"Shoenfeld","year":"2001","journal-title":"IMAJ"},{"issue":"1","key":"10.1016\/j.mehy.2009.08.008_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0749.1995.tb00775.x","article-title":"Antimelanoma antibodies in swine with spontaneously regressing melanoma","volume":"8","author":"Cui","year":"1995","journal-title":"Pigment Cell Res"},{"issue":"3","key":"10.1016\/j.mehy.2009.08.008_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0749.1993.tb00594.x","article-title":"Smyth chicken melanocyte autoantibodies \u2013 cross-species recognition, in-vivo binding, and plasma-membrane reactivity of the antiserum","volume":"6","author":"Searle","year":"1993","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.mehy.2009.08.008_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","article-title":"Identification of pigment cell antigens defined by vitiligo antibodies","volume":"98","author":"Cui","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","article-title":"Characterization of vitiligo antigens","volume":"8","author":"Cui","year":"1995","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.mehy.2009.08.008_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0923-1811(95)00427-0","article-title":"Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients","volume":"11","author":"Park","year":"1996","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.mehy.2009.08.008_bib35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2009.08.008_bib36","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","article-title":"Cloning of the gene coding for a share human melanoma antigen recognized by autologous T cell infiltrating into tumor","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2009.08.008_bib37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.179.3.1005","article-title":"Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes","volume":"179","author":"Bakker","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2009.08.008_bib38","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.154.8.3961","article-title":"Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor infiltrating T lymphocytes associated with in vivo tumor regression","volume":"154","author":"Kawakami","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2009.08.008_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2009.08.008_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein 1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.171.4.1375","article-title":"The melanoma antigen gp75 in the human homologue of the mouse b (brown) locus gene product","volume":"171","author":"Vijayasaradhi","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2009.08.008_bib42","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","article-title":"Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tryrosinase and tyrosinase-related protein-2 (TRP-2)","volume":"109","author":"Kemp","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2009.08.008_bib44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2009.08.008_bib45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.178.2.489","article-title":"The tyrosinase gene code for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"178","author":"Brichard","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2009.08.008_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.180.1.35","article-title":"A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"180","author":"Coulie","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2009.08.008_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase as an autoantigen in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2009.08.008_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","article-title":"Tyrosinase as an autoantigen in patients with vitiligo","volume":"105","author":"Baharav","year":"1996","journal-title":"Clin Exp Immunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709005477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709005477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:41:05Z","timestamp":1685126465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709005477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0306987709005477"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.08.008","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}